HLNCF (Haleon) Inventories, Work In Process : $33 Mil (As of Dec. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Haleon Inventories, Work In Process?

Work in process is the part of a manufacturer's inventory that is in the production process and has not yet been completed and transferred to the finished goods inventory. Haleon's work in process for the quarter that ended in Dec. 2024 was $33 Mil.

Haleon Inventories, Work In Process Historical Data

The historical data trend for Haleon's Inventories, Work In Process can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Haleon Inventories, Work In Process Chart

Haleon Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Inventories, Work In Process

Get a 7-Day Free Trial

94.09

62.50

42.63

25.32

32.87

Haleon Quarterly Data
	Dec19	Dec20	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Inventories, Work In Process	Get a 7-Day Free Trial												25.32	-	-	-	32.87

Haleon Inventories, Work In Process Calculation

That part of a manufacturer's inventory that is in the production process and has not yet been completed and transferred to the finished goods inventory. This account contains the cost of the direct material, direct labor, and factory overhead placed into the products on the factory floor. A manufacturer must disclose in its financial statements the cost of its work-in-process as well as the cost of finished goods and materials on hand.

Haleon Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Haleon PLC (OTCPK:HLNCF) » Definitions » Inventories, Work In Process

Comparable Companies

Traded in Other Exchanges

HLN:USA HLN1:Mexico HLN:Mexico HLNl:UK HLN:UK H6D0:Germany

Address

The Heights, Building 5, First Floor, Surrey, Weybridge, GBR, KT13 0NY

Website

https://www.haleon.com

Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.